Who to call at Acadia Pharmaceuticals Inc., and when
Fundz watches for the moments Acadia Pharmaceuticals Inc. starts buying, and tells you who to reach.
- An alert the day Acadia Pharmaceuticals Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Acadia Pharmaceuticals Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Acadia Pharmaceuticals Inc.. With Fundz connected, it knows.
Acadia Pharmaceuticals Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
acadia.comAI Executive Summary
AI-powered analysis of 8-K filing content
Acadia Pharmaceuticals director Daniel B. Soland notified the Board on October 28, 2025 that he was resigning from the Board and from his roles as a member and Chair of the Nominating and Corporate Governance Committee, effective October 30, 2025. The filing states the resignation was not the result of any dispute or disagreement with the Company or the Board.
Key Takeaways
Daniel B. Soland resigned from Acadia's Board of Directors effective October 30, 2025, after notifying the Board on October 28, 2025.
Soland also stepped down as a member and Chair of the Nominating and Corporate Governance Committee, so the Company must fill the chair role to maintain committee leadership.
2 more takeaways
Related Filings (5)
5 more filings from Acadia Pharmaceuticals Inc. in the last 90 days
Filing Overview
What This Means
Acadia Pharmaceuticals Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.